Müller, L.; Dabbiru, V.A.S.; Rutten, L.; Bos, R.; Zahn, R.; Handtke, S.; Thiele, T.; Palicio, M.; Esteban, O.; Broto, M.;
et al. Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT. Vaccines 2025, 13, 3.
https://doi.org/10.3390/vaccines13010003
AMA Style
Müller L, Dabbiru VAS, Rutten L, Bos R, Zahn R, Handtke S, Thiele T, Palicio M, Esteban O, Broto M,
et al. Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT. Vaccines. 2025; 13(1):3.
https://doi.org/10.3390/vaccines13010003
Chicago/Turabian Style
Müller, Luisa, Venkata A. S. Dabbiru, Lucy Rutten, Rinke Bos, Roland Zahn, Stefan Handtke, Thomas Thiele, Marta Palicio, Olga Esteban, Marta Broto,
and et al. 2025. "Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT" Vaccines 13, no. 1: 3.
https://doi.org/10.3390/vaccines13010003
APA Style
Müller, L., Dabbiru, V. A. S., Rutten, L., Bos, R., Zahn, R., Handtke, S., Thiele, T., Palicio, M., Esteban, O., Broto, M., Gordon, T. P., Greinacher, A., Wang, J. J., & Schönborn, L.
(2025). Recombinant Anti-PF4 Antibodies Derived from Patients with Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT) Facilitate Research and Laboratory Diagnosis of VITT. Vaccines, 13(1), 3.
https://doi.org/10.3390/vaccines13010003
